OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: Cancer Chemotherapy and Pharmacology
DOI: 10.1007/s00280-010-1544-1
Authors: T. Doi, H. Murakami, A. Ohtsu, N. Fuse, T. Yoshino, N. Yamamoto, N. Boku, Y. Onozawa, C-P. Hsu, K. S. Gorski, G. Friberg, T. Kawaguchi, T. Sasaki
Institutions: National Cancer Center Hospital East, Shizuoka Cancer Center, Amgen (United States), Takeda (Japan)
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: DR5, monoclonal antibodies, advanced solid tumors, safety and tolerability, pharmacokinetics, dose-limiting toxicity, monocytes, receptor occupancy, Japanese patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2005246279
FWCI: 2.394
Cites: 32
Cited by: 54
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms